An API maker in Bizen, Japan, has joined a growing list of Japanese drugmakers to be criticized by the FDA in warning letters. In this case, the agency was concerned enough to also ban the company’s products from the U.S. until it makes changes to its manufacturing.Original Article
FDA warns API maker Daito Kasei Kogyo, bans some products
